RAC 2.92% $1.94 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-140

  1. 3,262 Posts.
    lightbulb Created with Sketch. 345
    Unfortunately, LT investors have heard all this before, numerous times. Extended timelines have been trendy for the last 4 years with Race.
    Previously, retail investors had the appetite to wait, which they did. But now, many have eaten as many carrots as they can stomach.

    I don't hold much hope for even the so called 'Bonus' options to stay in the money for long. The word 'Bonus' being a creative description for CR from (yet again) retail investors' pockets - just like the last retail based CR, of which the majority of the whopping $30m was spent, with very little to show for it.

    Also, I'd hoped we weren't going to use that phrase anymore after previous discussions - "Outsized returns" - because ANY return would be good right now what.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.